Literature DB >> 20466925

The selection landscape of malaria parasites.

M J Mackinnon1, K Marsh.   

Abstract

Malaria parasites have to survive and transmit within a highly selective and ever-changing host environment. Because immunity to malaria is nonsterilizing and builds up slowly through repeated infections, commonly the parasite invades a host that is immunologically and physiologically different from its previous host. During the course of infection, the parasite must also keep pace with changes in host immune responses and red-blood-cell physiology. Here, we describe the "selection landscape" of the most virulent of the human malaria parasites, Plasmodium falciparum, and the adaptive mechanisms it uses to navigate through that landscape. Taking a cost-benefit view of parasite fitness, we consider the evolutionary outcomes of the most important forces of selection operating on the parasite, namely immunity, host death, drugs, mosquito availability, and coinfection. Given the huge potential for malaria parasite evolution in the context of the recently renewed effort to eradicate malaria, a deeper understanding of P. falciparum adaptation is essential.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466925     DOI: 10.1126/science.1185410

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  68 in total

1.  Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice.

Authors:  Ramesh Gujjar; Farah El Mazouni; Karen L White; John White; Sharon Creason; David M Shackleford; Xiaoyi Deng; William N Charman; Ian Bathurst; Jeremy Burrows; David M Floyd; David Matthews; Frederick S Buckner; Susan A Charman; Margaret A Phillips; Pradipsinh K Rathod
Journal:  J Med Chem       Date:  2011-05-12       Impact factor: 7.446

2.  Malaria: The vector as protector.

Authors:  Andrew F Read; Nicole Mideo
Journal:  Nature       Date:  2013-05-29       Impact factor: 49.962

3.  How selection forces dictate the variant surface antigens used by malaria parasites.

Authors:  Maite Severins; Don Klinkenberg; Hans Heesterbeek
Journal:  J R Soc Interface       Date:  2011-07-06       Impact factor: 4.118

4.  Searching for Achilles' heel: can rational design of malaria vaccines overcome antigenic diversity?

Authors:  Eleanor M Riley
Journal:  Pathog Glob Health       Date:  2014-03       Impact factor: 2.894

5.  Recurring infection with ecologically distinct HPV types can explain high prevalence and diversity.

Authors:  Sylvia L Ranjeva; Edward B Baskerville; Vanja Dukic; Luisa L Villa; Eduardo Lazcano-Ponce; Anna R Giuliano; Greg Dwyer; Sarah Cobey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-05       Impact factor: 11.205

6.  Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study.

Authors:  Steve M Taylor; Alejandro Antonia; Gaoqian Feng; Victor Mwapasa; Ebbie Chaluluka; Malcolm Molyneux; Feiko O ter Kuile; Stephen J Rogerson; Steven R Meshnick
Journal:  Infect Genet Evol       Date:  2011-11-20       Impact factor: 3.342

Review 7.  Immune mechanisms in malaria: new insights in vaccine development.

Authors:  Eleanor M Riley; V Ann Stewart
Journal:  Nat Med       Date:  2013-02       Impact factor: 53.440

8.  Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites.

Authors:  Alyse N Douglass; Heather S Kain; Marian Abdullahi; Nadia Arang; Laura S Austin; Sebastian A Mikolajczak; Zachary P Billman; Jen C C Hume; Sean C Murphy; Stefan H I Kappe; Alexis Kaushansky
Journal:  Mol Ther       Date:  2015-02-04       Impact factor: 11.454

9.  Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network.

Authors:  Germán Plata; Tzu-Lin Hsiao; Kellen L Olszewski; Manuel Llinás; Dennis Vitkup
Journal:  Mol Syst Biol       Date:  2010-09-07       Impact factor: 11.429

10.  Suppression of host p53 is critical for Plasmodium liver-stage infection.

Authors:  Alexis Kaushansky; Albert S Ye; Laura S Austin; Sebastian A Mikolajczak; Ashley M Vaughan; Nelly Camargo; Peter G Metzger; Alyse N Douglass; Gavin MacBeath; Stefan H I Kappe
Journal:  Cell Rep       Date:  2013-03-07       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.